Cognizance Biomarkers

Developing EvoScoreDX, a diagnostic that rapidly and accurately identifies epileptic seizures, yielding improved outcomes at significant cost savings.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded July 2012
  • Employees 4
  • Incorporation Type C-corp
  • Website cognizancebio.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free